Targeting atherosclerosis progression following pneumonia through pulmonary delivery of omega-3 fatty acids in nanoparticle carriers

通过纳米颗粒载体中的 omega-3 脂肪酸肺部递送来靶向肺炎后动脉粥样硬化的进展

• 批准号: 476336
• 负责人: Stotts Cameron
• 金额: $ 7.65万
• 依托单位: Ottawa Heart Institute Research Corporation (Ontario)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-11-01 至 2025-11-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=476336&lang=en
• 关键词: Atherosclerosis; Nanoparticles; Omega-3 Fatty Acids; Pneumonia; Therapeutics

Cardiovascular disease is the second leading cause of death in Canada. Atherosclerosis, a type of cardiovascular disease, is caused by the build-up of fats in the blood vessels. In an attempt to remove the fat, immune cells are recruited through a process

心血管疾病是加拿大第二大死亡原因。动脉粥样硬化是一种心血管疾病，是由血管中的脂肪堆积引起的。为了去除脂肪，免疫细胞通过一个过程被招募